Skip to Content

A/P 25/15 (Oseni 25 mg / 15 mg)

Generic Name: alogliptin/pioglitazone

Pill with imprint A/P 25/15 is Yellow, Round and has been identified as Oseni 25 mg / 15 mg. It is supplied by Takeda Pharmaceuticals America, Inc..

Oseni is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Oseni 25 mg / 15 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for A/P 25/15

Oseni 25 mg / 15 mg A/P 25/15

Oseni

Generic Name
alogliptin/pioglitazone
Imprint
A/P 25/15
Strength
25 mg / 15 mg
Color
Yellow
Size
9.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Antidiabetic combinations
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Takeda Pharmaceuticals America, Inc.
National Drug Code (NDC)
64764-0251
Inactive Ingredients
mannitol, microcrystalline cellulose, croscarmellose sodium, magnesium stearate, hypromellose 2910 (6 mPa.s), titanium dioxide, polyethylene glycol 8000, magnesium silicate, lactose monohydrate, ferric oxide yellow, shellac, ferrosoferric oxide, butyl alcohol, alcohol

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "A/P 25/15"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.